A previous study on fibrosarcoma cells showed an increase in MMP9 activity could be explained by miR-520c and miR-373 that acts by targeting the 3’UTR of mTOR and SIRT1 and its downstream effectors and kinases to inactivating signaling pathways that negatively regulate MMP9 expression [21]. The gene discussed is MTOR; the disease is fibrosarcoma.